secwatch.observer — SEC 8-K summary
======================================

Issuer:     BLOOMIOS, INC. (—)
CIK:        0001138608
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001477932-22-008045
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 5.03, 2.01, 2.03, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bloomios acquires Infusionz from Upexi for $23.5M; adds $22M annual revenue
---------------------------------------------------------------------------

- Acquired Infusionz, a CBD gummy manufacturer, from Upexi (NASDAQ:UPXI) for $23.5M ($5.5M cash + $18M non-cash).
- Non-cash consideration: $4.5M debenture, $5M note, and $8.5M Series D preferred stock to Upexi.
- Debenture offering raised $6.25M new cash; aggregate principal $13.9M (incl. 15% OID) to fund the deal.
- Acquisition expected to double production capacity and add over $22M in annualized gross revenue.
- Bloomios plans to use the acquisition to uplist to Nasdaq and enter direct-to-consumer market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138608/000147793222008045/0001477932-22-008045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138608/000147793222008045/blms_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-008045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer